权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Treatment for Alcohol Use Disorder in Medicaid Managed Care

医疗补助管理护理中酒精使用障碍的治疗

基本信息

批准号：
10403668
负责人：
Amanda J Abraham
金额：
$ 62.57万
依托单位：
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-05-10 至 2025-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10403668
关键词：
AODR mortality Accounting Address Affect Age Alcohols American Behavior Therapy Caring Centers for Disease Control and Prevention (U.S.)Cessation of life Clinical Contracts Data Data Set Diagnosis Emergency department visit Ensure Health Health Services Accessibility Heavy Drinking Hospitalization Improve Access Investigation Kentucky Link Managed Care Medicaid Methods Morality Ohio Outcome Patients Pharmaceutical Preparations Policies Population Positioning Attribute Public Health Randomized Relapse Research Selection Bias Series Structure Substance Use Disorder Time United States Vulnerable Populations acute care adverse outcome alcohol abuse therapy alcohol availability alcohol use disorder craving design evidence base health knowledge indexing innovation knowledge base longitudinal analysis medication compliance mortality overtreatment prior authorization programs public health priorities treatment effect treatment services

项目摘要

PROJECT SUMMARY As the nation continues to grapple with rising alcohol-related hospitalization and mortality, expanding access to alcohol use disorder (AUD) treatment remains an urgent public health priority. While Medicaid is positioned to be a key policy lever to improve access to AUD treatment and reduce mortality among vulnerable populations, many state Medicaid programs do not cover the full continuum of AUD treatment and use utilization management parameters that may restrict access. Moreover, most state Medicaid programs contract with managed care organizations (MCOs). While over 70% of all Medicaid enrollees participate in MCO plans, little is known about how these plans cover AUD treatment. To fill this gap in the scientific evidence, we will conduct the first multi-state study of the effects of Medicaid MCO coverage and utilization management design on AUD treatment receipt and outcomes. The study will encompass 142 MCO plans, across 18 states, for the full continuum of treatment. We also propose to make use of innovative random auto-assignment methods in two state Medicaid programs. Our specific aims will include: (1) estimating how MCO plans’ coverage and utilization management designs are associated with progression through the major stages of identification and treatment of AUD (diagnosis, initiation, engagement, and retention); (2) estimating how MCO plans’ coverage and utilization management parameters are associated with alcohol-related emergency department visits and hospitalizations; and (3) estimating how progression through the stages of identification and treatment of AUD is associated with alcohol-related mortality. The proposed study will be the first comprehensive investigation of the effects of MCO coverage for AUD treatment on treatment receipt and outcomes – evidence without which the care of a large fraction of the AUD population is compromised. As alcohol-related hospitalization and mortality continue to rise, evidence regarding the impact of Medicaid MCO coverage for AUD treatment is urgently needed. This research will equip policymakers with evidence-based guidance on how to structure MCO contractual arrangements to ensure appropriate and efficient access to AUD treatment. 1

项目概要随着国家继续努力应对与酒精相关的住院率和死亡率上升的问题，扩大获得服务的机会酒精使用障碍（AUD）治疗仍然是一个紧迫的公共卫生优先事项。虽然医疗补助计划的定位是成为改善弱势群体获得 AUD 治疗并降低死亡率的关键政策杠杆，许多州的医疗补助计划不涵盖 AUD 治疗和使用的整个连续过程可能限制访问的管理参数。此外，大多数州医疗补助计划都与管理式医疗组织 (MCO)。虽然超过 70% 的医疗补助参与者参与了 MCO 计划，但很少有人参与了解这些计划如何承保 AUD 治疗。为了填补科学证据方面的这一空白，我们将进行第一个关于医疗补助 MCO 覆盖范围和使用管理设计对澳元影响的多州研究治疗收据和结果。该研究将涵盖 18 个州的 142 个 MCO 计划，全面覆盖连续治疗。我们还建议在两个方面使用创新的随机自动分配方法州医疗补助计划。我们的具体目标将包括：(1) 估计 MCO 计划的覆盖范围和利用管理设计与识别和识别的主要阶段的进展相关联。 AUD 的治疗（诊断、启动、参与和保留）； (2) 估计MCO计划的覆盖范围和利用管理参数与酒精相关的急诊科就诊和住院治疗； (3) 估计 AUD 的识别和治疗阶段的进展情况与酒精相关的死亡率有关。拟议的研究将是首次全面调查 AUD 治疗的 MCO 承保对治疗接受和结果的影响 – 没有证据很大一部分澳元人口的护理受到损害。由于酒精相关的住院治疗和死亡率持续上升，有关医疗补助 MCO 覆盖范围对 AUD 治疗影响的证据是急需。这项研究将为政策制定者提供关于如何构建基于证据的指导。 MCO 合同安排，确保适当且有效地获得 AUD 待遇。 1